Stem cells derived from patient placentas reproduce preeclampsia features
A new model developed by researchers at Kumamoto University and collaborators from Tohoku University and Kyushu University could advance research into preeclampsia and other pregnancy complications. The team has developed a robust method for producing human trophoblast stem cells (hTSCs) from late-gestation placentas, opening a new avenue for studying pregnancy complications using patient-derived…
Researchers at Kumamoto University and their international collaborators have developed a novel technique to generate human trophoblast stem cells (hTSCs) from late-gestation placentas. This breakthrough could significantly advance research into pregnancy complications, including preeclampsia. The study, published in the Proceedings of the National Academy of Sciences, details the method's potential in creating patient-specific models of preeclampsia, offering insights into the disease's molecular mechanisms and paving the way for new therapeutic strategies.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
